ArticleCurrent protocols2026
Zebrafish Embryos to Profile Nano(bio)materials: A Modular Platform for Developmental Toxicity, Neurotoxicity, and Inflammation-Regeneration Assays.
Article in Current protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Zebrafish embryos provide a rapid, low-cost in vivo platform to profile the developmental, neurotoxic, and immunomodulatory effects of engineered nano(bio)materials within a single vertebrate system. This article presents a modular workflow that integrates standardized fish embryo acute toxicity (FET) testing, chemically assisted dichlorination, inflammatory challenge, and regeneration assays to evaluate both bio-based and synthetic nanoparticles. First, embryos are exposed to nanomaterials under FET conditions and subjected to quantitative morphometric analysis to establish sublethal concentration ranges and detect subtle growth defects. Sensitivity to nano(bio)material exposure is enhanced by a pronase-based dechorionation procedure, which removes the chorion to promote direct particle-tissue contact while maintaining acceptable baseline viability. Immunoinflammatory responses are probed using two complementary modules: microinjection of Pseudomonas aeruginosa lipopolysaccharide (LPS) into the yolk sac to induce acute systemic inflammation and caudal fin wounding to elicit a localized inflammatory and regenerative response. Across these models, we combine qPCR panels of cytokine and Wnt/β-catenin pathway genes with Sudan Black B staining of neutrophils and neutral red vital staining of macrophages, providing accessible cellular and molecular readouts in wild-type embryos. Together, these protocols constitute a harmonized, technically accessible pipeline that enables comparative safety and bioactivity profiling of diverse nano(bio)materials and supports their assessment within safe-and-sustainable-by-design frameworks. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Nanoparticle preparation and suspension, and embryo dechorionation procedure (pronase solution) Basic Protocol 2: Sudan Black B staining protocol Basic Protocol 3: Neutral red staining protocol Basic Protocol 4: LPS microinjection protocol Basic Protocol 5: Wound inflammation model generation protocol.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.